Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis
NCT ID: NCT07040332
Last Updated: 2025-07-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
140 participants
OBSERVATIONAL
2025-05-10
2029-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multicenter Registration Study on Allergic Bronchopulmonary Aspergillosis
NCT06645210
Cytokine Profile of Allergic Bronchopulmonary Aspergillosis
NCT03643185
Interest of IgE Directed Against Recombinant Antigens of Aspergillus Fumigatus in the Diagnosis of Allergic Bronchopulmonary Aspergillosis (ABPA)
NCT07055230
Effects of Environmental Fungal Exposure on Bronchial Asthma, ABPA and Bronchiectasis
NCT07313904
Protocol TARC-ABPA
NCT01710930
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
allergic bronchopulmonary aspergillosis
No intervention
fungal-sensitized asthma
No intervention
control group
No intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Meets the diagnostic criteria for fungal-sensitized asthma.
Exclusion Criteria
* Malignant tumor.
* Blood system disease.
* autoimmune system disease.
* History of pulmonary tuberculosis.
* Patients with a history of smoking or still smoking.
* Invasive pulmonary fungal disease.
* Contraindications electronic bronchoscopy
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Pulmonary Hospital, Tongji University School of Medicine
UNKNOWN
Fudan University
OTHER
Guizhou Provincial People's Hospital
OTHER
The First Hospital of Jilin University
OTHER
Qilu Hospital of Shandong University
OTHER
Qianfoshan Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Qian Qi
Dr.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Respiratory, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, #16766, Jingshi Road, Jinan City, Shandong Province, China
Jinan, Shandong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
QFS-2025-074
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.